355 related articles for article (PubMed ID: 31933128)
1. The pathogenic role of the GIP/GIPR axis in human endocrine tumors: emerging clinical mechanisms beyond diabetes.
Regazzo D; Barbot M; Scaroni C; Albiger N; Occhi G
Rev Endocr Metab Disord; 2020 Mar; 21(1):165-183. PubMed ID: 31933128
[TBL] [Abstract][Full Text] [Related]
2. The GIP/GIPR axis is functionally linked to GH-secretion increase in a significant proportion of
Regazzo D; Losa M; Albiger NM; Terreni MR; Vazza G; Ceccato F; Emanuelli E; Denaro L; Scaroni C; Occhi G
Eur J Endocrinol; 2017 May; 176(5):543-553. PubMed ID: 28179449
[TBL] [Abstract][Full Text] [Related]
3. The glucose-dependent insulinotropic polypeptide receptor is overexpressed amongst GNAS1 mutation-negative somatotropinomas and drives growth hormone (GH)-promoter activity in GH3 cells.
Occhi G; Losa M; Albiger N; Trivellin G; Regazzo D; Scanarini M; Monteserin-Garcia JL; Fröhlich B; Ferasin S; Terreni MR; Fassina A; Vitiello L; Stalla G; Mantero F; Scaroni C
J Neuroendocrinol; 2011 Jul; 23(7):641-9. PubMed ID: 21554434
[TBL] [Abstract][Full Text] [Related]
4. Extensive expertise in endocrinology: glucose-dependent insulinotropic peptide-dependent Cushing's syndrome.
Lacroix A
Eur J Endocrinol; 2023 Mar; 188(3):R56-R72. PubMed ID: 36857084
[TBL] [Abstract][Full Text] [Related]
5. Hypermethylator Phenotype and Ectopic GIP Receptor in GNAS Mutation-Negative Somatotropinomas.
Hage M; Chaligné R; Viengchareun S; Villa C; Salenave S; Bouligand J; Letouzé E; Tosca L; Rouquette A; Tachdjian G; Parker F; Lombès M; Lacroix A; Gaillard S; Chanson P; Kamenický P
J Clin Endocrinol Metab; 2019 May; 104(5):1777-1787. PubMed ID: 30376114
[TBL] [Abstract][Full Text] [Related]
6. The role of GIP in α-cells and glucagon secretion.
El K; Campbell JE
Peptides; 2020 Mar; 125():170213. PubMed ID: 31785304
[TBL] [Abstract][Full Text] [Related]
7. Disruption of GIP/GIPR axis in human adipose tissue is linked to obesity and insulin resistance.
Ceperuelo-Mallafré V; Duran X; Pachón G; Roche K; Garrido-Sánchez L; Vilarrasa N; Tinahones FJ; Vicente V; Pujol J; Vendrell J; Fernández-Veledo S
J Clin Endocrinol Metab; 2014 May; 99(5):E908-19. PubMed ID: 24512489
[TBL] [Abstract][Full Text] [Related]
8. Adrenal GIPR expression and chromosome 19q13 microduplications in GIP-dependent Cushing's syndrome.
Lecoq AL; Stratakis CA; Viengchareun S; Chaligné R; Tosca L; Deméocq V; Hage M; Berthon A; Faucz FR; Hanna P; Boyer HG; Servant N; Salenave S; Tachdjian G; Adam C; Benhamo V; Clauser E; Guiochon-Mantel A; Young J; Lombès M; Bourdeau I; Maiter D; Tabarin A; Bertherat J; Lefebvre H; de Herder W; Louiset E; Lacroix A; Chanson P; Bouligand J; Kamenický P
JCI Insight; 2017 Sep; 2(18):. PubMed ID: 28931750
[TBL] [Abstract][Full Text] [Related]
9. Glucose-dependent insulinotropic polypeptide (GIP) receptor antagonists as anti-diabetic agents.
Gasbjerg LS; Gabe MBN; Hartmann B; Christensen MB; Knop FK; Holst JJ; Rosenkilde MM
Peptides; 2018 Feb; 100():173-181. PubMed ID: 29412817
[TBL] [Abstract][Full Text] [Related]
10. A naturally occurring GIP receptor variant undergoes enhanced agonist-induced desensitization, which impairs GIP control of adipose insulin sensitivity.
Mohammad S; Patel RT; Bruno J; Panhwar MS; Wen J; McGraw TE
Mol Cell Biol; 2014 Oct; 34(19):3618-29. PubMed ID: 25047836
[TBL] [Abstract][Full Text] [Related]
11. Adrenocortical overexpression of gastric inhibitory polypeptide receptor underlies food-dependent Cushing's syndrome.
N'Diaye N; Tremblay J; Hamet P; De Herder WW; Lacroix A
J Clin Endocrinol Metab; 1998 Aug; 83(8):2781-5. PubMed ID: 9709947
[TBL] [Abstract][Full Text] [Related]
12. Effects on pancreatic Beta and other Islet cells of the glucose-dependent insulinotropic polypeptide.
Khan R; Tomas A; Rutter GA
Peptides; 2020 Mar; 125():170201. PubMed ID: 31751656
[TBL] [Abstract][Full Text] [Related]
13. A novel GIP receptor splice variant influences GIP sensitivity of pancreatic beta-cells in obese mice.
Harada N; Yamada Y; Tsukiyama K; Yamada C; Nakamura Y; Mukai E; Hamasaki A; Liu X; Toyoda K; Seino Y; Inagaki N
Am J Physiol Endocrinol Metab; 2008 Jan; 294(1):E61-8. PubMed ID: 17971513
[TBL] [Abstract][Full Text] [Related]
14. TCF1 links GIPR signaling to the control of beta cell function and survival.
Campbell JE; Ussher JR; Mulvihill EE; Kolic J; Baggio LL; Cao X; Liu Y; Lamont BJ; Morii T; Streutker CJ; Tamarina N; Philipson LH; Wrana JL; MacDonald PE; Drucker DJ
Nat Med; 2016 Jan; 22(1):84-90. PubMed ID: 26642437
[TBL] [Abstract][Full Text] [Related]
15. Structural and pharmacological characterization of novel potent and selective monoclonal antibody antagonists of glucose-dependent insulinotropic polypeptide receptor.
Ravn P; Madhurantakam C; Kunze S; Matthews E; Priest C; O'Brien S; Collinson A; Papworth M; Fritsch-Fredin M; Jermutus L; Benthem L; Gruetter M; Jackson RH
J Biol Chem; 2013 Jul; 288(27):19760-72. PubMed ID: 23689510
[TBL] [Abstract][Full Text] [Related]
16. Functional expression of glucose-dependent insulinotropic polypeptide receptors is coupled to differentiation in a human adipocyte model.
Weaver RE; Donnelly D; Wabitsch M; Grant PJ; Balmforth AJ
Int J Obes (Lond); 2008 Nov; 32(11):1705-11. PubMed ID: 18779825
[TBL] [Abstract][Full Text] [Related]
17. Pleiotropic effects of GIP on islet function involve osteopontin.
Lyssenko V; Eliasson L; Kotova O; Pilgaard K; Wierup N; Salehi A; Wendt A; Jonsson A; De Marinis YZ; Berglund LM; Taneera J; Balhuizen A; Hansson O; Osmark P; Dunér P; Brøns C; Stancáková A; Kuusisto J; Bugliani M; Saxena R; Ahlqvist E; Kieffer TJ; Tuomi T; Isomaa B; Melander O; Sonestedt E; Orho-Melander M; Nilsson P; Bonetti S; Bonadonna R; Miccoli R; Delprato S; Marchetti P; Madsbad S; Poulsen P; Vaag A; Laakso M; Gomez MF; Groop L
Diabetes; 2011 Sep; 60(9):2424-33. PubMed ID: 21810601
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular biology of the GIP receptor.
Greenwell AA; Chahade JJ; Ussher JR
Peptides; 2020 Mar; 125():170228. PubMed ID: 31812593
[TBL] [Abstract][Full Text] [Related]
19. Glucose-dependent insulinotropic polypeptide (GIP) and its receptor (GIPR): cellular localization, lesion-affected expression, and impaired regenerative axonal growth.
Buhren BA; Gasis M; Thorens B; Müller HW; Bosse F
J Neurosci Res; 2009 Jun; 87(8):1858-70. PubMed ID: 19170165
[TBL] [Abstract][Full Text] [Related]
20. Effects of High Glucose Levels and Glycated Serum on GIP Responsiveness in the Pancreatic Beta Cell Line HIT-T15.
Puddu A; Sanguineti R; Montecucco F; Viviani GL
J Diabetes Res; 2015; 2015():326359. PubMed ID: 26221611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
